|
BAY32-5915
|
8-羥基喹啉-2-羧酸
|
1571-30-8
|
|
β-Sitostenone
|
豆甾-4-烯-3-酮
|
1058-61-3
|
|
IPAG
|
化合物 T22870
|
193527-91-2
|
|
NB-360
|
2-Pyridinecarboxamide, N-[3-[(3R,6R)-5-amino-3,6-dihydro-3,6-dimethyl-6-(trifluoromethyl)-2H-1,4-oxazin-3-yl]-4-fluorophenyl]-5-cyano-3-methyl-
|
1262857-73-7
|
|
Nifeviroc
|
Nifeviroc
|
934740-33-7
|
|
(Rac)-BRD0705
|
化合物 T12664
|
1597440-03-3
|
|
HBC
|
Benzeneacetonitrile, 4-cyano-α-[[4-[(2-hydroxyethyl)methylamino]phenyl]methylene]-
|
156840-13-0
|
|
GZD856 formic
|
化合物 GZD856 FORMIC
|
2804039-78-7
|
|
Cinnamaldehyde
|
肉桂醛
|
104-55-2
|
|
Keap1-Nrf2-IN-16
|
(R)-5-羥基-1,7-二苯基-3-庚酮
|
100761-20-4
|
|
SMANT hydrochloride
|
化合物T23370
|
1177600-74-6
|
|
PDE10-IN-1
|
3-Methyl-2-((1S,2S)-2-(quinolin-2-yl)cyclopropyl)-3H-iMidazo[4,5-f]quinoline
|
1516896-09-5
|
|
Pembrolizumab
|
派姆單抗
|
1374853-91-4
|
|
AKT-IN-6
|
INCB-047775
|
1430056-54-4
|
|
3-Hydroxy-2-methylpyridine
|
3-羥基-2-甲基吡啶
|
1121-25-1
|
|
JAB-3068 hydrochloride
|
SHP2-IN-6 HYDROCHLORIDE
|
2169223-49-6
|
|
Mepolizumab
|
美泊利單抗
|
196078-29-2
|
|
Myricetin 3-O-glucoside
|
楊梅素-3-O-Β-D-葡萄糖苷
|
19833-12-6
|
|
AKT-IN-1
|
6-[4-(1-氨基環(huán)丁基)苯基]-5-苯基-3-吡啶甲酰胺
|
1357158-81-6
|
|
123C4
|
化合物123C4
|
2034159-30-1
|
|
Flunarizine
|
NaV1.7 inhibitor-1
|
1494585-79-3
|
|
AZD9898
|
AZD9898
|
2042347-69-1
|
|
Benpyrine
|
BENPYRINE
|
2550398-89-3
|
|
AZ3976
|
化合物 T23764
|
1418747-15-5
|
|
Mitiperstat
|
AZD4831
|
1933460-19-5
|
|
L-Ascorbic acid-
|
化合物HOMO-VK-II-36
|
1479049-35-8
|
|
Golgicide A-2
|
GOLGICIDE A-2
|
1394285-50-7
|
|
BMS-986202
|
BMS-986202
|
1771691-34-9
|
|
Thioquinapiperifil dihydrochloride
|
KF-31327
|
204077-66-7
|
|
Sofosbuvir impurity G
|
索氟布韋雜質(zhì)
|
1337482-15-1
|
|
PARP-2-IN-3
|
B014
|
1215208-59-5
|
|
CWP232228
|
化合物CWP232228
|
1144044-02-9
|
|
AMG8380
|
PF-06649298
|
1854061-16-7
|
|
XEN723
|
1072803-08-7
|
1072803-08-7
|
|
RIP2 Kinase Inhibitor 3
|
RIP2 Kinase Inhibitor 3
|
1398053-50-3
|
|
Dimethyl malonate
|
丙二酸二甲酯
|
108-59-8
|
|
MAT2A inhibitor 4
|
化合物T9262
|
1391934-91-0
|
|
TRPC6-IN-3
|
化合物 TRPC6-IN-3
|
2311863-36-0
|
|
Bufarenogin
|
偽異沙蟾毒精
|
17008-65-0
|
|
PF-04880594
|
化合物AD57
|
1093380-42-7
|
|
MRT-83
|
[1,1'-Biphenyl]-4-carboxaMide, N-[5-[[iMino[(3,4,5-triMethoxybenzoyl)aMino]Methyl]aMino]-2-Methylphenyl]-
|
1263131-92-5
|
|
Alirocumab
|
阿利庫單抗
|
1245916-14-6
|
|
CL264
|
CL264
|
1510712-69-2
|
|
PF-04745637
|
1-(4-chlorophenyl)-N-(2-(4-hydroxy-4-(trifluoromethyl)piperidin-1-yl)-3-phenylpropyl)cyclopentanecarboxamide
|
1917294-46-2
|
|
Tyk2-IN-7
|
TYK2-IN-7 (COMPOUND 48)
|
1609391-90-3
|
|
2-Iodoacetamide
|
2-碘乙酰胺
|
144-48-9
|
|
WEE1-IN-3
|
JUN76288
|
2272976-28-8
|
|
XMU-MP-3
|
XMU-MP-3
|
2031152-08-4
|
|
FTT5
|
FTT5
|
2328129-27-5
|
|
FGTI-2734 mesylate
|
|
2702297-24-1
|
|
Galloylpaeoniflorin
|
沒食子酰芍藥苷
|
122965-41-7
|
|
VU0359595
|
(1R,2R)-N-([S]-1-{4-[5-BROMO-2-OXO-2,3-DIHYDRO-1H-BENZO(D)IMIDAZOL-1-YL]PIPERIDIN-1-YL}PROPAN-2-YL)-2-PHENYLCYCLOPROPANECARBOXAMIDE;VU0359595
|
1246303-14-9
|
|
N-trans-Caffeoyltyramine
|
N-trans-caffeoyltyramine
|
103188-48-3
|
|
XD14
|
CS-2672
|
1370888-71-3
|
|
CFTR corrector 6
|
DAPAGLIFLOZIN
|
2226970-01-8
|
|
3,5-Di-tert-butylphenol
|
3,5-二叔丁基苯酚
|
1138-52-9
|
|
Cbl-b-IN-1
|
CBL-B-IN-1
|
2368841-84-1
|
|
Posenacaftor sodium
|
POSENACAFTOR SODIUM
|
2095064-06-3
|
|
Povorcitinib phosphate
|
POVORCITINIB磷酸鹽
|
1637677-33-8
|
|
Hispolon
|
HISPOLON
|
173933-40-9
|
|
Chrysin 6-C-arabinoside 8-C-glucoside
|
白楊素 6-C-阿拉伯糖 8-C-葡萄糖苷
|
185145-33-9
|
|
SB-747651A dihydrochloride
|
SB-747651A二鹽酸鹽
|
1781882-72-1
|
|
MLT-943
|
MLT943
|
1832576-04-1
|
|
Bisindolylmaleimide V
|
雙吲哚馬來酰亞胺
|
113963-68-1
|
|
Bcl-xL antagonist 2
|
BCL-XL拮抗劑2
|
1235032-75-3
|
|
3-Pyridinemethanol
|
3-吡啶甲醇
|
100-55-0
|
|
ROCK2-IN-2
|
ROCK2-IN-2
|
1995065-79-6
|
|
(R)-Posenacaftor sodium
|
(R)-POSENACAFTOR SODIUM
|
2095064-09-6
|
|
CCT369260
|
化合物 CCT369260
|
2647503-57-7
|
|
MitoTam bromide, hydrobromide
|
MITOTAM BROMIDE, HYDROBROMIDE
|
1634624-73-9
|
|
GSM-1
|
4-Piperidineacetic acid, 1-[(1R)-1-(4-chlorophenyl)-4-methylpentyl]-2-[4-(trifluoromethyl)phenyl]-, (2S,4R)-
|
884600-68-4
|
|
IMT1B
|
化合物IMT1B
|
2304621-06-3
|
|
13,21-Dihydroeurycomanone
|
Picras-3-ene-2,16-dione, 11,20-epoxy-1,11,12,14,15-pentahydroxy-, (1β,11β,12α,15β)-
|
129587-06-0
|
|
CDK-IN-9
|
|
1903783-77-6
|
|
BCL6-IN-4
|
BCL6-IN-4
|
2253879-65-9
|
|
JAK2-IN-7
|
JAK2-IN-7
|
2593402-36-7
|
|
WH-4-025
|
WH-4-025
|
1876463-35-2
|
|
Pitavastatin sodium
|
Β-香樹脂醇乙酸酯
|
1616-93-9
|
|
Chrysosplenol D
|
貓眼草酚
|
14965-20-9
|
|
Decapeptide-12
|
SIRT-IN-1
|
1431411-60-7
|
|
EHT 5372
|
化合物 EHT 5372
|
1425945-63-6
|
|
Tazofelone
|
化合物TAZOFELONE
|
107902-67-0
|
|
(E/Z)-Sivopixant
|
化合物(E/Z)-SIVOPIXANT
|
1640808-39-4
|
|
X77
|
化合物 X77
|
2455518-33-7
|
|
TLR7/8-IN-1
|
TLR7/8-IN-1
|
2205095-75-4
|
|
Arnicolide D
|
2-(2-氨基-4-甲基-5-嘧啶基)-ALPHA,ALPHA-二甲基-4-(4-嗎啉基)噻吩并[3,2-D]嘧啶-6-甲醇
|
1033739-92-2
|
|
AM103
|
AM 103
|
1147872-22-7
|
|
PR-104A
|
PR 104A
|
680199-06-8
|
|
ALDH1A3-IN-3
|
4-異丙氧基苯甲醛
|
18962-05-5
|
|
BU224 hydrochloride
|
化合物BU 226 HYDROCHLORIDE
|
1186195-56-1
|
|
AChE-IN-27
|
化合物WAY-298592
|
177028-90-9
|
|
MELK-IN-1
|
Nintedanib Impurity L
|
2095596-44-2
|
|
MitoTam iodide, hydriodide
|
MITOTAM IODIDE, HYDRIODIDE
|
1634624-74-0
|
|
TPN171
|
TPN171
|
1229018-87-4
|
|
Wnt pathway activator 2
|
Wnt pathway activator 2
|
1360540-82-4
|
|
D-Galacturonic acid hydrate
|
甲殼素
|
1398-61-4
|
|
LCAHA
|
Cholan-24-amide, N,3-dihydroxy-, (3α,5β)-
|
117094-40-3
|
|
KW-8232
|
KW-8232
|
217813-15-5
|
|
SIRT2-IN-8
|
奧司他韋雜質(zhì)B(2-疊氮雜合物)
|
115687-05-3
|
|
Minzasolmin
|
化合物 MINZASOLMIN
|
1802518-92-8
|